nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—malignant glioma—meningioma	0.528	0.528	CtDrD
Temozolomide—brain cancer—meningioma	0.265	0.265	CtDrD
Temozolomide—melanoma—meningioma	0.206	0.206	CtDrD
